Therapeutic strategies for durable response in plasma cell granulomas in the central nervous system

2018 ◽  
Vol 98 (4) ◽  
pp. 1027-1029
Author(s):  
Ameet Patel ◽  
Mehmet H. Kocoglu ◽  
Akash Kaul
2021 ◽  
Vol 21 ◽  
pp. S437-S438
Author(s):  
Carine Ribeiro Franzon ◽  
Andressa Oliveira Martin Wagner ◽  
Annelise Correa Wengerkievicz Lopes ◽  
Douglas Gebauer Bona ◽  
Talita Bertazzo Schmitz

2019 ◽  
Vol 59 (3) ◽  
pp. 135-139
Author(s):  
Takayuki Murase ◽  
Atsushi Inagaki ◽  
Ayako Masaki ◽  
Keiichiro Fujii ◽  
Tomoko Narita ◽  
...  

Neurosurgery ◽  
1994 ◽  
Vol 35 (4) ◽  
pp. 744-747 ◽  
Author(s):  
John Hsiang ◽  
David Moorhouse ◽  
David Barba

2021 ◽  
Vol 15 ◽  
Author(s):  
Xiuqi Chen ◽  
Wenmei Lu ◽  
Danhong Wu

As a type of nicotinamide adenine dinucleotide (NAD+)-dependent deacetylases, sirtuin 2 (SIRT2) is predominantly found in the cytoplasm of cells in the central nervous system (CNS), suggesting its potential role in neurological disorders. Though SIRT2 is generally acknowledged to accelerate the development of neurological pathologies, it protects the brain from deterioration in certain circumstances. This review summarized the complex roles SIRT2 plays in the pathophysiology of diverse neurological disorders, compared and analyzed the discrete roles of SIRT2 in different conditions, and provided possible explanations for its paradoxical functions. In the future, the rapid growth in SIRT2 research may clarify its impacts on neurological disorders and develop therapeutic strategies targeting this protein.


Neurosurgery ◽  
1994 ◽  
Vol 35 (4) ◽  
pp. 744???747 ◽  
Author(s):  
John Hsiang ◽  
David Moorhouse ◽  
David Barba

1993 ◽  
Vol 693 (1 Pediatric AID) ◽  
pp. 229-244 ◽  
Author(s):  
LEE E. EIDEN ◽  
DIANNE M. RAUSCH ◽  
ANNA da CUNHA ◽  
ELISABETH A. MURRAY ◽  
MELVYN HEYES ◽  
...  

2021 ◽  
Vol 21 ◽  
pp. S257
Author(s):  
Carine Ribeiro Franzon ◽  
Andressa Oliveira Martin Wagner ◽  
Annelise Correa Wengerkievicz Lopes ◽  
Douglas Gebauer Bona ◽  
Talita Bertazzo Schmitz

Neurosurgery ◽  
1989 ◽  
Vol 24 (3) ◽  
pp. 429-434 ◽  
Author(s):  
Karen M. Weidenheim ◽  
Wallace G. Campbell ◽  
H. Warren Goldman

Abstract Hematopoietic proliferations rich in plasma cells rarely occur within the central nervous system without the involvement of other organ systems. Depending on their histological pattern and cellular composition, several different terms, including plasmacytoma, plasma cell granuloma, hyalinizing plasmacytic granulomatosis, and inflammatory meningioma, are used for these lesions. We report a left temporal dural lesion composed of plasma cells, lymphocytes, histiocytes, and rare eosinophils with hyaline changes and a suggestion of follicle formation, which stained predominantly for IgG and kappa light chains. This lesion arose in an otherwise healthy 52-year-old woman. Free kappa light chains without a monoclonal peak were found in the urine. We are aware of only two other heterogeneous, predominantly plasmacytic, solitary dural lesions that were found to be monoclonal on immunohistochemical examination. The label atypical monoclonal plasma cell hyperplasia appears to suit the morphological characteristics of our lesion. We suggest that a spectrum of solitary plasmacytic lesions may occur within the central nervous system and that atypical plasma cell hyperplasias have the potential to evolve into plasmacytoma. The preneoplastic nature of this lesion and its potential for evolution to malignant myeloma should be considered when planning treatment and lifelong follow-up for patients.


Author(s):  
Sarah A Neely ◽  
Jill M Williamson ◽  
Anna Klingseisen ◽  
Lida Zoupi ◽  
Jason J Early ◽  
...  

Regeneration of myelin (remyelination) in the central nervous system (CNS) has long been thought to be principally mediated by newly generated oligodendrocytes, a premise underpinning therapeutic strategies for demyelinating diseases, including multiple sclerosis (MS). Recent studies have indicated that oligodendrocytes that survive demyelination can also contribute to remyelination, including in MS, but it is unclear how remyelination by surviving oligodendrocytes compares to that of newly generated oligodendrocytes. Here we studied oligodendrocytes in MS, and also imaged remyelination in vivo by surviving and new oligodendrocytes using zebrafish. We define a previously unappreciated pathology in MS, myelination of neuronal cell bodies, which is recapitulated during remyelination by surviving oligodendrocytes in zebrafish. Live imaging also revealed that surviving oligodendrocytes make very few new sheaths, but can support sheath growth along axons. In comparison, newly made oligodendrocytes make abundant new sheaths, properly targeted to axons, and exhibit a much greater capacity for regeneration.


Sign in / Sign up

Export Citation Format

Share Document